Sort
21,281 grants matching “influenza”
Nasal RNA response to respiratory viral infections
$264,875Tao Pan · University Of Chicago · R21 · FY2022 · AI
Mechanism of action of codon pair bias
$264,841Allen Bruce Futcher · State University New York Stony Brook · R01 · FY2014 · GM
Coupling Machine Learning with Agent-Based Modeling to Design a Universal Influenza Vaccine
$264,812Kayla Sprenger · University Of Colorado · R21 · FY2022 · AI
C19 SARS-CoV-2-specific T cells in the infected nasel epithelium
$264,749David M Koelle · University Of Washington · R21 · FY2021 · AI
Inhaled Brevetoxins: Health Effects and Mechanisms
$264,718Janet M. Benson · University Of North Carolina Wilmington · P01 · FY2010 · ES
Mucosal epithelial remodeling and autophagy
$264,702Thaddeus S Stappenbeck · Washington University · U19 · FY2014 · AI
Role of cannabinoid receptor 1 in lung injury and resolution
$264,688William A Altemeier · University Of Washington · R21 · FY2019 · AI
Botanical Core
$264,660Amar G. Chittiboyina · University Of Mississippi · U19 · FY2020 · AT
Pan-Influenza virus inhibitors: Small molecules that disrupt host ADAR1-viral NS1 interactions
$264,650Balaji Manicassamy · University Of Chicago · R21 · FY2015 · AI
Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases
$264,633H. Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Dendritic Cell Strategies to Tumor Reactive T Cells
$264,591University Of Pittsburgh At Pittsburgh · R01 · FY2005 · CA
Proteomic Analysis of the Innate Antiviral Response
$264,589University Of Washington · R21 · FY2003 · AI
BACTERIAL PHOSPHORYLCHOLINE AND PATHOGENESIS
$264,514University Of Pennsylvania · R01 · FY2002 · AI
Complement in S.pneumoniae otitis Media
$264,497Hua Hua Tong · Ohio State University · R01 · FY2011 · DC
COVID-19 imprints airway basal cells to impair epithelium regeneration
$264,341Xingbin Ai · Massachusetts General Hospital · R21 · FY2023 · AI
Rationally Designed Inhibitors of Cytotoxic T Cells
$264,250Drexel University · R21 · FY2002 · AI
Impact of mucosal adjuvanted vaccines on virus transmission in preclinical animal models for SARS-CoV-2 and influenza virus infection
$264,250Michael Schotsaert · Icahn School Of Medicine At Mount Sinai · R21 · FY2024 · AI
Project 3: Tolerance of Viral/Bacterial Co-infections
$264,197Amanda M Jamieson · Brown University · P20 · FY2019 · GM
Project 4: Role of Antecedent Influenza Infection in Severity and Outcome of Hemorrhagic MRSA Pneumonia
$264,098Tanyalak Parimon · Idaho Veterans Research / Education Fdn · P20 · FY2016 · GM
Measuring the Immunome: Genomic Approaches to B Cell Repertoire
$264,076Stephen R Quake · Stanford University · U19 · FY2009 · AI
The Biopharmaceutical Product Development Services Program
$264,055Science Applications International Corp · N01 · FY2012 · AI
RSV infections augment Cl2 induced injury to the respiratory system
$264,029Sadis Matalon · University Of Alabama At Birmingham · U54 · FY2008 · ES
Polarization of Dendritic Cells by CD8 T cells
$263,996University Of Pittsburgh At Pittsburgh · R01 · FY2004 · CA
PA-21-259, SBIR, Phase I, Self-Amplifying RNA Replicon-Based Platform for Generating Multivalent Influenza Vaccine
$263,991Valerian Nakaar · Carogen Corporation · R43 · FY2022 · IP
Infection and Immunity: The Pathogenesis of Host-Microbe Interactions
$263,961Paul M. Dunman · University Of Rochester · T32 · FY2022 · AI